5
Oseaspre Consultants Ltd
OSEASPRECONSULTANTSLTD NSE
Oseaspre Consultants Ltd
Commercial ServicesNSE: OSEASPRECONSULTANTSLTD BSE: OSEASPR Diversified Services
Key Fundamentals
MicrocapDiversified ServicesCommercial ServicesMarket Cap
₹0.00 Cr
P/E Ratio
0
EBITDA
₹-0.20 Cr
Return on Equity
-8.6%
Debt to Equity
0
Book Value
₹40.22
EPS
₹0
52W High
₹0
52W Low
₹0
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Oseaspre Consultants Ltd insights
27 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
2- Company has low interest coverage ratio.
- Company has a low return on equity of -10.6% over last 3 years.
Growth Rate
Revenue Growth
-100.00% ↘
Net Income Growth
-600.00% ↘
Cash Flow Change
-15.79% ↘
ROE
-251.68% ↘
ROCE
-239.33% ↘
EBITDA Margin (Avg.)
-2911.26% ↘
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.18 | 0 | 0 | 0 | 0 |
| Expenses | 0.03 | 0.03 | 0.05 | 0.04 | 0.06 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 |
| Operating Profit | -0.03 | -0.03 | -0.05 | -0.04 | -0.06 | -0.04 | -0.05 | -0.05 | 0.13 | -0.05 | -0.05 | -0.05 | -0.06 |
| OPM % | — | — | — | — | — | — | — | — | 72.22% | — | — | — | — |
| Other Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.02 | -0.02 | -0.04 | -0.03 | -0.05 | -0.03 | -0.04 | -0.04 | 0.14 | -0.04 | -0.04 | -0.04 | -0.05 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 20% |
| Net Profit | -0.02 | -0.02 | -0.04 | -0.03 | -0.05 | -0.03 | -0.04 | -0.04 | 0.14 | -0.04 | -0.04 | -0.04 | -0.06 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.24 | 0.24 | 0.07 | 0.06 | 0.07 | 0.05 | 0.03 | 0.04 | 0.04 | 0 | 0.18 | 0 |
| Expenses | 0.04 | 0.17 | 0.12 | 0.12 | 0.13 | 0.16 | 0.12 | 0.14 | 0.13 | 0.19 | 0.18 | 0.2 |
| Operating Profit | 0.2 | 0.07 | -0.05 | -0.06 | -0.06 | -0.11 | -0.09 | -0.1 | -0.09 | -0.19 | 0 | -0.2 |
| OPM % | 83.33% | 29.17% | -71.43% | -100% | -85.71% | -220% | -300% | -250% | -225% | — | 0% | — |
| Other Income | 0.03 | 0.03 | 0.03 | 0.03 | 0.07 | 0.05 | 0.05 | 0.05 | 0.02 | 0.05 | 0.04 | 0.03 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.23 | 0.1 | -0.02 | -0.03 | 0.01 | -0.06 | -0.04 | -0.05 | -0.07 | -0.14 | 0.04 | -0.17 |
| Tax % | 17.39% | 20% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5.88% |
| Net Profit | 0.18 | 0.08 | -0.02 | -0.03 | 0.01 | -0.06 | -0.04 | -0.05 | -0.07 | -0.14 | 0.04 | -0.18 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -966.67% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Reserves | 0.78 | 0.86 | 0.91 | 0.87 | 0.88 | 0.76 | 0.72 | 0.67 | 0.6 | 0.46 | 0.5 | 1.92 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.05 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.05 |
| Total Liabilities | 1.03 | 1.07 | 1.13 | 1.09 | 1.1 | 0.97 | 0.93 | 0.88 | 0.81 | 0.69 | 0.73 | 2.17 |
| Fixed Assets | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| CWIP | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.29 | 0 | 0.08 | 0.07 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.73 | 1.06 | 1.04 | 1.01 | 1.02 | 0.96 | 0.92 | 0.87 | 0.8 | 0.68 | 0.72 | 2.16 |
| Total Assets | 1.03 | 1.07 | 1.13 | 1.09 | 1.1 | 0.97 | 0.93 | 0.88 | 0.81 | 0.69 | 0.73 | 2.17 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.02 | -0.2 | -0.1 | -0.09 | -0.07 | -0.11 | -0.07 | -0.09 | -0.11 | -0.19 | -0.19 | -0.22 |
| Investing | 0.69 | -0.04 | -0.36 | 0.14 | 0.04 | 0.07 | 0.11 | 0.08 | 0.07 | 0.28 | 0.11 | 2.31 |
| Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.7 | -0.23 | -0.46 | 0.05 | -0.03 | -0.04 | 0.04 | -0.01 | -0.04 | 0.08 | -0.08 | 2.09 |
| Free Cash Flow | 0.02 | -0.2 | -0.1 | -0.09 | -0.07 | -0.11 | -0.07 | -0.09 | -0.11 | -0.19 | -0.19 | -0.22 |
| CFO/OP | 10 | -200 | 200 | 150 | 100 | 100 | 78 | 90 | 122 | 100 | — | 10 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 385 | — |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 385 | — |
| Working Capital Days | -60.83 | 0 | 0 | 0 | 52.14 | 73 | 0 | 274 | 183 | — | 466 | — |
| ROCE % | 25.84% | 9.8% | -1.84% | -2.75% | 0.93% | -5.88% | -4.26% | -5.59% | -8.38% | -19.18% | 5.88% | -13.48% |
Documents
1
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31St March, 2026 And Recommendation Of Dividend, If Any, For The Financial Year Ended 31St March, 2026.
11h - Board to meet on 15 May 2026 to approve FY26 audited results and consider dividend. 11h - Board to meet on 15 May 2026 to approve FY26 audited results and consider dividend.
2
Closure of Trading Window
26 Mar - Trading window closed 1 April 2026 until 48 hours after audited results for quarter/year ended 31 March 2026. 26 Mar - Trading window closed 1 April 2026 until 48 hours after audited results for quarter/year ended 31 March 2026.
3
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
25 Feb - Sold 48,000 INOR Medical Products Ltd shares to Nowrosjee Wadia & Sons on Feb 25, 2026. 25 Feb - Sold 48,000 INOR Medical Products Ltd shares to Nowrosjee Wadia & Sons on Feb 25, 2026.
4
Announcement under Regulation 30 (LODR)-Press Release / Media Release
14 Feb - Extract of unaudited Q3 and nine months financial results for period ended 31 Dec 2025 published 14 Feb 2026. 14 Feb - Extract of unaudited Q3 and nine months financial results for period ended 31 Dec 2025 published 14 Feb 2026.
5
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING OF OSEASPRE CONSULTANTS LIMITED HELD ON 12TH FEBRUARY, 2026.
12 Feb - Unaudited Q3 and nine-month results ended 31 Dec 2025: Q3 loss ₹3.90L, nine-month loss ₹11.80L. 12 Feb - Unaudited Q3 and nine-month results ended 31 Dec 2025: Q3 loss ₹3.90L, nine-month loss ₹11.80L.
Frequently Asked Questions about Oseaspre Consultants Ltd
What does Oseaspre Consultants Ltd do?
Oseaspre Consultants is engaged in the business of provision of technical know-how or rendering of services in connection with the provision of technical know-how and to provide services in areas of accountancy and secretarial, etc.
Where is Oseaspre Consultants Ltd (509782) listed?
Oseaspre Consultants Ltd is listed on the Indian stock exchanges. It is listed on NSE: OSEASPRECONSULTANTSLTD and BSE: OSEASPR. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Oseaspre Consultants Ltd belong to?
Oseaspre Consultants Ltd operates in the Commercial Services sector within the Diversified Services industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Oseaspre Consultants Ltd?
Oseaspre Consultants Ltd has a market capitalisation of approximately ₹0. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Oseaspre Consultants Ltd?
The Price-to-Earnings (PE) ratio of Oseaspre Consultants Ltd is 0.00. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Oseaspre Consultants Ltd?
Over the past 52 weeks, Oseaspre Consultants Ltd has traded between a low of ₹0 and a high of ₹0. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Oseaspre Consultants Ltd?
Oseaspre Consultants Ltd has a Return on Equity (ROE) of -8.60%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Oseaspre Consultants Ltd on Tapetide?
On Tapetide, you can view Oseaspre Consultants Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Oseaspre Consultants is engaged in the business of provision of technical know-how or rendering of services in connection with the provision of technical know-how and to provide services in areas of accountancy and secretarial, etc.
Website oseaspre.com
Face Value ₹ 10